Top Abstract Purchase Related
Home
>
Node
>
Subnode

Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy

Fayssoil, A.

Indian Heart Journal 62(3): 273

2010

ISSN/ISBN: 0019-4832
PMID: 21275309
Document Number: 642393
Duchenne muscular dystrophy (DMD) is an X-linkedrecessive disorder caused by the absence of dystrophin. Cardiac dysfunction is a classical complication in this disease. Most DMD patients remain asymptomatic for years in spite of the progression of cardiac dysfunction because of their limited daily activities. Angiotensin-converting enzyme inhibitors and beta-blockers may delay the onset and the progression of cardiac dysfunction and have to be recommended earlier in this disease.

Document emailed within 1 workday
Secure & encrypted payments

Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Voronkov, L.G.; Serdiuk, T.E.; Riabenko, D.V. 2000: Use of inhibitors of the angiotensin-converting enzyme and the beta-adrenoblocker metoprolol combined in treatment of chronic cardiac insufficiency Likars'ka Sprava 2000(7-8): 77-80
Ohtahara, A.; Hisatome, I.; Yamamoto, Y.; Furuse, M.; Sonoyama, K.; Furuse, Y.; Hamada, T.; Katoh, M.; Watanabe, M.; Kinugawa, T.; Ogino, K.; Igawa, O.; Shimomura, T.; Murakami, F.; Yamamoto, T.; Shigemasa, C. 2001: The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and alpha1-blockers Journal of Hypertension 19(3 Pt 2): 575-582
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Wiecek, A. 1992: Effect of calcium channel blockers and angiotensin i converting enzyme inhibitors on the kidney Polski Tygodnik Lekarski 47(49-50): 1115-1117
Arnaout, M.S.; Khalil, A.; Alam, S.E. 2003: Influence of angiotensin converting enzyme inhibitors on stable myocardial ischemia in menopausal cardiac patients Clinical and Experimental Obstetrics and Gynecology 30(1): 43-46
Amodeo, C. 1990: Inhibitors of angiotensin-converting enzyme in cardiac insufficiency Arquivos Brasileiros de Cardiologia 54(2): 97-99
Mareev, V.I.; Lopatin, I.M.; Dzhakhangirov, T.S.; Gkhani, P.; Ageev, F.T.; Belenkov, I.N. 1993: Comparative study on use of angiotensin-converting enzyme inhibitors and cardiac glycosides in the treatment of cardiac insufficiency Kardiologiia 33(12): 23-31; 3-4
Frohlich, E.D.; Horinaka, S. 1991: Cardiac and aortic effects of angiotensin converting enzyme inhibitors Hypertension 18(4 Suppl): Ii2-Ii7
Correia, J.F. 1991: Therapy of cardiac insufficiency with angiotensin converting enzyme inhibitors. new concepts-new strategies Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 10(11): 851-857
González-Juanatey, J.R. 2000: Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose Medicina Clinica 114 Suppl. 2: 24-27
Chyatte, S.B.; Rudman, D.; Patterson, J.H.; Ahmann, P.; Jordan, A. 1974: Human growth hormone in myopathy: myotonic dystrophy, duchenne muscular dystrophy, and limb-girdle muscular dystrophy Southern Medical Journal 67(2): 170-172
Shulman, N.B. 1988: Treatment of hypertension in black patients with angiotensin-converting enzyme inhibitors Journal of the National Medical Association 80(3): 265-272
Montgomery, L. 2001: Are angiotensin-converting enzyme (ACE) inhibitors effective in preventing migraine in nonhypertensive patients? Journal of Family Practice 50(4): 299
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422